标题:Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China
作者:Li, Shunping; Wang, Min; Liu, Liu; Chen, Gang
作者机构:[Li, Shunping; Liu, Liu] Shandong Univ, Sch Hlth Care Management, Jinan, Shandong, Peoples R China.; [Li, Shunping; Liu, Liu] Shandong Univ, NHC Key 更多
通讯作者:Chen, G
通讯作者地址:[Chen, G]Monash Univ, Monash Business Sch, Ctr Hlth Econ, Clayton, Vic, Australia.
来源:EUROPEAN JOURNAL OF CANCER CARE
出版年:2019
卷:28
期:2
DOI:10.1111/ecc.12965
关键词:breast cancer; EQ-5D-5L; health state utility; quality of life; SF-6D;; time trade-off
摘要:Accurately measuring health state utilities is crucial for health economic evaluation. This study empirically investigated both indirect approaches (including using the latest version of five-level EQ-5D questionnaire, EQ-5D-5L and the popular SF-6D), as well as a direct approach (the time trade-off, TTO) for eliciting utilities in breast cancer patients. A valid sample of 608 breast cancer patients (48% TNM Stages III/IV) in mainland China was analysed. Mean utilities elicited from the TTO, EQ-5D-5L and SF-6D were 0.80, 0.83 and 0.65 respectively. There is poor to fair agreement between direct and indirect approaches on measuring health state utilities with breast cancer patients. The absolute agreement was higher between EQ-5D-5L and SF-6D utilities (intraclass correlation coefficient, ICC = 0.55) than between TTO and EQ-5D-5L/SF-6D utilities (ICCs < 0.3). Regression analyses found that both EQ-5D-5L and SF-6D utilities were responsive to five out of eight breast cancer-specific symptom and functional scales. In sum, criterion and known-group validities of three health state utility measures which were investigated in this research suggest that, the EQ-5D-5L is currently the optimal approach (followed by the SF-6D) to elicit health state utilities from breast cancer patients in mainland China.
收录类别:SCOPUS;SCIE;SSCI
Scopus被引频次:2
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057774310&doi=10.1111%2fecc.12965&partnerID=40&md5=3c32e06e0d1c4e896821095c29b5579c
TOP